Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23431270 | 0.92 | LMNA (0.33) | MAPTLMNAHTTKMT2A | |
| SCHEMBL23911721 | 0.92 | TSPO (0.32) | — | |
| SCHEMBL23911726 | 0.90 | NR4A2 (0.32) | — | |
| SCHEMBL23911716 | 0.87 | — | — | |
| SCHEMBL23911713 | 0.87 | NR4A2 (0.31) | — | |
| SCHEMBL23911709 | 0.83 | P2RX4 (0.31) | — | |
| SCHEMBL30010276 | 0.80 | KDM4E (0.49) | NPSR1KDM4EITGB2ICAM1ITGAL | |
| SCHEMBL13365990 | 0.80 | KDM4E (0.49) | NPSR1KDM4EITGB2ICAM1ITGAL | |
| SCHEMBL24210010 | 0.80 | GPR3 (0.46) | NPSR1KDM4EMAPTMEN1LMNA | |
| SCHEMBL23911720 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220020937-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-01-20 | — | — | US | disclosed |
| US-11145823-B2 | Heterocyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11145823-B2 | Heterocyclic compound and organic light emitting device including the same | TRPC1, ODC1, DDT | NPSR1 4208/4885KDM4E 1975/4885ITGB2 2725/4885 |
| US-20220020937-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | TRPC1, ODC1, DDT | NPSR1 4143/4885KDM4E 1600/4885ITGB2 2908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.